Companies / Haemonetics Corporation

Haemonetics Corporation

NYSECIK 313143BOSTON, MAhaemonetics.com ↗

Financials · FY2026

Revenue$1.33B
Net income$97.31M
Total debt$1.19B
Cash$223.38M
Diluted EPS$2.05
Shares outstanding45.5M

Ownership

45.5M shares outstanding · as of Jul 31, 2026
7.0%10%+ / strategic
Ownership
10%+ / strategic6.95%3,163,104
Institutions107.57%48,941,262
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 350

View all →
HolderValue% of shares
BlackRock, Inc.$443.19M12.99%
Vanguard Group Inc$381.60M10.46%
Neuberger Berman Group LLC$309.88M8.50%
AQR Capital Management, LLC$185.68M7.38%
State Street Corporation$136.36M4.00%
Fmr LLC$106.35M2.92%
Citadel Advisors LLC$103.27M2.83%
Holocene Advisors, LP$101.33M2.78%
The Goldman Sachs Group, Inc.$98.31M2.70%
North Peak Capital Management, LLC$88.40M2.42%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
AQR Capital Management, LLCPassive13G—3,163,104—
North Peak Capital Management, LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
———405024100—